Moderna Inc
MRNA
Market Cap$48.09B
Close$
$-71.77
158.5% downside
Current Fair Value
158.5% downsideOvervalued by 158.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $48.09 Billion |
|---|---|
| Enterprise Value | $40.14 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-12.34 |
| Beta | 1.21 |
| Outstanding Shares | 382,879,612 |
| Avg 30 Day Volume | 3,428,688 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -10.2 |
|---|---|
| PEG | 0.64 |
| Price to Sales | 9.44 |
| Price to Book Ratio | 3.72 |
| Enterprise Value to Revenue | 7.79 |
| Enterprise Value to EBIT | -7.81 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
ESG Score
No data
About Moderna Inc
CEO: Stephane Bancel